Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|April 12, 2016
Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah's Witness with mutant IDH1/NPM1/NRAS Acute Myeloid LeukemiaAshkan Emadi, Najeebah A Bade, Brandi Stevenson, et al.
Clinical Advances in Hematology & Oncology : H&O|September 25, 2010
Castleman disease in the 21st century: an update on diagnosis, assessment, and therapyFrits van Rhee, Katie Stone, Susann Szmania, et al.
ACG Case Reports Journal|October 9, 2023
The Sigmoid Colon as an Unusual Primary Site of T Cell Lymphoma in a Patient Presenting With Brain MetastasisMohammad Bourmaf, Kiran K Motwani, Isaac McCool, et al.
British Journal of Haematology|April 8, 2017
Marizomib for central nervous system-multiple myelomaAshraf Badros, Zeba Singh, Binod Dhakal, et al.
Blood|May 3, 2017
Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myelomaAshraf Badros, Elizabeth Hyjek, Ning Ma, et al.
Blood|April 23, 2013
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myelomaSaad Z Usmani, Jeffrey Sawyer, Adam Rosenthal, et al.
Cancer Chemotherapy and Pharmacology|November 10, 2017
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemiaAshkan Emadi, Jennie Y Law, Erin T Strovel, et al.
Pageof 1